BML-259

• Target :

  CDK

• Related Pathways :

  Cell Cycle/Checkpoint

• Purity :

  0.9984

• Bioactivity :

  BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

• Smiles :

  CC(C)c1cnc(NC(=O)Cc2ccccc2)s1

• Molecular Formula :

  C14H16N2OS

• Molecular Weight :

  260.35

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  267654-00-2